Piramal acquires US inhalation anesthetic gas distribution unit
This article was originally published in Scrip
Piramal Healthcarehas acquired RxElite Holdings, the inhalation anaesthetic gas distribution subsidiary of RxElite Inc, for about $4.2 million in cash.
You may also be interested in...
Piramal is continuing on its acquisitive spree, snapping up a basket of injectable products from Janssen that are expected to give the diversified Indian group a foothold in the $20bn-plus global generic injectable hospital drugs market.
WTO director general says pharma could have done more on voluntary licensing for COVID-19 vaccines and also calls for better transparency of pricing and contracts to ensure “a level playing field” when it comes to saving lives.
CEO Umang Vohra outlines where Cipla is heading in its priority areas of lung route therapies and antimicrobial resistance. He also weighs in on the simmering issue of intellectual property waivers for COVID-19 vaccines.